BIOSPECIFICS TECHNOLOGIES CORP - Attachement

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R0DWpB3uOkY0tyeFUE7zSOoHrpei1CVwMbMUlLozWGEiWzROCmvz05oWXKlk2QrQ Mbagw5pEzxK92eiy5goKJA== 0001062993-10-001094.txt : 20100405 0001062993-10-001094.hdr.sgml : 20100405 20100405115121 ACCESSION NUMBER: 0001062993-10-001094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100402 FILED AS OF DATE: 20100405 DATE AS OF CHANGE: 20100405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Thomas CENTRAL INDEX KEY: 0001355189 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 10729828 MAIL ADDRESS: STREET 1: 1764 BRIAR PLACE CITY: MERRICK STATE: NY ZIP: 11566 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0303 4 2010-04-02 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001355189 Wegman Thomas 1764 BRIAR PLACE MERRICK NY 11566 1 1 1 0 President Stock Option (Right to Buy) .83 2010-04-02 4 A 0 50000 0 A 2010-04-02 2020-04-01 Common Stock, $0.001 par value 50000 100000 D On September 6, 2006, the reporting person was granted an option to purchase 100,000 shares of the Issuer's Common Stock. The option vests in two equal installments based on the reporting person's satisfaction of two distinct performance conditions. The first performance related condition was satisfied on October 24, 2007, resulting in the vesting of the option as to 50,000 shares. The second performance related condition was satisfied on April 2, 2010, resulting in the vesting of the option as to the remaining 50,000 shares. Exhibit 24 - Power of Attorney /s/ Thomas L. Wegman by Carl A. Valenstein, attorney in fact 2010-04-05 EX-24 2 powerofattorney.htm POWER OF ATTORNEY BIOSPECIFICS TECHNOLOGIES CORP - Attachement - Filed by newsfilecorp.com

POWER OF ATTORNEY

(Section 16 Filings)

Know all by these presents, that the undersigned hereby constitutes and appoints Carl A. Valenstein, Kevin A. Hughes and Kelly E. W. Grez, each individually, as the undersigned's true and lawful attorneys-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and director of BioSpecifics Technologies Corp. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, or any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of any such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by any such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or such attorneys-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that neither of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 28th day of January, 2010.

/s/ Thomas L. Wegman
Name: Thomas L. Wegman

-----END PRIVACY-ENHANCED MESSAGE-----